Consequently, it is difficult to compare the pharmacogenetics of ADRs with chemotherapy in general and with that used in colorectal cancer (CRC) in particular. [7] As many studies focus on ...
A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery.” ...
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.
Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...
Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.
Genetic testing and at-home screenings for colon, prostate and cervical cancer give workers and their families access to ...
The Common Terminology Criteria for Adverse Events can be found at [201] and the WHO criteria can be found at [202]. 5-FU: 5-fluorouracil; ADR: Adverse drug reaction; CRC: Colorectal cancer; mCRC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback